Determine Announces 3rd Quarter Fiscal Year 2017 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
110
Determine Announces 3rd Quarter Fiscal Year 2017 Financial Results, Exceeding Revenue and Earnings Expectations

CARMEL, IN--(Marketwired - Feb 9, 2017) - Determine , Inc. ( NASDAQ : DTRM ), a leading global provider of SaaS enterprise Source to Pay and Enterprise Contract Lifecycle Management solutions, including cloud-based strategic sourcing, supplier management, contract management and procure-to-pay solutions, announced financial results for its third fiscal quarter ended December 31, 2016.

Q3 FY2017 GAAP Financial Highlights:

  • GAAP revenue was $6.9 million in Q3 FY2017, compared to $6.6 million in Q2 FY2017, representing a 4.1% increase quarter-over-quarter, and compared to $7.1 million in Q3 FY2016 GAAP revenue, representing a 3.5% decrease year-over-year.
  • GAAP gross profit percentage increased to 48.8% in Q3 FY2017, compared to 47.7% in Q2 FY2017, representing a quarter-over-quarter increase of 1.1 percentage points, and compared to 51.9% in Q3 FY2016, representing a 3.1 percentage points decrease year-over-year.
  • Deferred revenues increased 11.1% to $10.0 million in Q3 FY2017 from $9.0 million in Q3 FY2016.
  • GAAP net loss was $2.2 million or ($0.18) per share in Q3 FY2017, compared to $3.2 million or ($0.28) per share in Q2 FY2017, representing a $0.10 improvement per share quarter-over-quarter; in Q3 FY2016 the GAAP net loss was $2.8 million or ($0.25) per share.

                                                                          (in thousands, except per share amounts)

 
GAAP Financial Measures   Q3     Q2     Q3     Change     Change     Nine Months  
  FY 2017     FY 2017     FY 2016     Q/Q     Y/Y     FY 2017'     FY 2016'     Change Y/Y  
Revenue - total   $ 6,852     $ 6,584     $ 7,100       4.1 %     (3.5 %)   $ 19,928     $ 20,080       (0.8 %)
Revenue - recurring   $ 5,054     $ 5,145     $ 5,354       (1.8 %)     (5.6 %)   $ 15,267     $ 15,862       (3.8 %)
Revenue - non-recurring   $ 1,798     $ 1,439     $ 1,746       24.9 %     3.0 %   $ 4,661     $ 4,218       10.5 %
Gross profit - total   $ 3,341     $ 3,138     $ 3,682       6.5 %     (9.3 %)   $ 9,865     $ 10,494       (6.0 %)
Gross profit - recurring   $ 3,277     $ 3,442     $ 3,538       (4.8 %)     (7.4 %)   $ 10,182     $ 10,859       (6.2 %)
Gross profit/ (loss) - non-recurring   $ 64     $ (304 )   $ 144       121.0 %     (55.6 %)   $ (317 )   $ (365 )     13.2 %
Gross margin - total     48.8 %     47.7 %     51.9 %     1.1 pts       (3.1 pts )     49.5 %     52.3 %     (2.8 pts )
Gross margin - recurring     64.8 %     66.9 %     66.1 %     (2.1 pts )     (1.3 pts )     66.7 %     68.5 %     (1.8 pts )
Gross margin - non recurring     3.5 %     (21.1 %)     8.2 %     24.6 pts       (4.7 pts )     (6.8 %)     (8.7 %)     1.9 pts  
Net loss   $ (2,193 )   $ (3,207 )   $ (2,845 )     31.6 %     22.9 %   $ (7,743 )   $ (10,212 )     24.2 %
EPS   $ (0.18 )   $ (0.28 )   $ (0.25 )   $ 0.10     $ 0.07     $ (0.67 )   $ (0.90 )   $ 0.23  
                                                                 

Q3 FY2017 Non-GAAP Financial Highlights:

  • Non-GAAP revenue was $6.9 million in Q3 FY2017, compared to $6.6 million in Q2 FY2017, representing a 4.1% quarter-over-quarter increase, and compared to $7.2 million in Q3 FY2016, representing a 4.7% decrease year-over-year.
  • Non-GAAP gross profit percentage was 54.4% in Q3 FY2017, compared to 52.5% in Q2 FY2017, representing a 1.9 percentage point increase, and compared to 57.5% in Q3 FY2016, representing a 3.1 percentage point decrease.
  • Non-GAAP net loss was $1.0 million or ($0.08) per share in Q3 FY2017, compared to $2.0 million or ($0.17) per share in Q2 FY2017, representing an improvement of $0.09 per share quarter-over-quarter, compared to $1.5 million or ($0.13) per share in Q3 FY2016, representing a $0.05 improvement per share year-over-year.
  • Billings decreased 3.3% to $7.5 million in Q3 FY2017 from $7.8 million in Q3 FY2016. Billings, a non-GAAP measure, are defined as revenue plus the change in deferred revenues.
  • Non-GAAP EBITDA was ($0.2) million in Q3 FY2017, and compared to ($1.4) million in Q3 FY2016, representing an improvement of $1.2 million year-over-year.

(in thousands, except per share amounts)                                                                          

 
Non-GAAP Financial Measures   Q3     Q2     Q3     Change     Change     Nine Months  
  FY 2017     FY 2017     FY 2016     Q/Q     Y/Y     FY 2017'     FY 2016'     Change Y/Y  
Revenue - total   $ 6,852     $ 6,584     $ 7,187       4.1 %     (4.7 %)   $ 19,936     $ 20,308       (1.8 %)
Revenue - recurring   $ 5,054     $ 5,145     $ 5,400       (1.8 %)     (6.4 %)   $ 15,275     $ 16,021       (4.7 %)
Revenue - non-recurring   $ 1,798     $ 1,439     $ 1,787       24.9 %     0.6 %   $ 4,661     $ 4,287       8.7 %
Gross profit - total   $ 3,726     $ 3,460     $ 4,135       7.7 %     (9.9 %)   $ 10,896     $ 11,677       (6.7 %)
Gross profit - recurring   $ 3,591     $ 3,710     $ 3,859       (3.2 %)     (7.0 %)   $ 11,037     $ 11,736       (6.0 %)
Gross profit/( loss) - non-recurring   $ 135     $ (250 )   $ 276       154.0 %     (51.1 %)   $ (141 )   $ (59 )     (139.0 %)
Gross margin - total     54.4 %     52.5 %     57.5 %     1.9 pts       (3.1 pts )     54.7 %     57.5 %     (2.8 pts )
Gross margin - recurring     71.0 %     72.1 %     71.5 %     (1.1 pts )     (0.5 pts )     72.3 %     73.3 %     (1.0 pts )
Gross margin - non recurring     7.5 %     (17.4 %)     15.5 %     24.9 pts       (8.0 pts )     (3.0 %)     (1.4 %)     (1.6 pts )
Net loss   $ (1,010 )   $ (1,959 )   $ (1,503 )     48.4 %     32.8 %   $ (4,253 )   $ (4,585 )     7.2 %
EPS   $ (0.08 )   $ (0.17 )   $ (0.13 )   $ 0.09     $ 0.05     $ (0.37 )   $ (0.45 )   $ 0.08  
Billings   $ 7,545     $ 5,770     $ 7,800       30.8 %     (3.3 %)   $ 19,595     $ 20,667       (5.2 %)
                                                                 

"This quarter we are very pleased by our return to the million dollar range for new Annualized Bookings, with quarter-over-quarter new sales growing at a rate in excess of 30%. Driving the sales performance was our disruptive, new Determine Cloud Platform offering, with over 90% of our new customers opting for the platform for their Source-to-Pay or Enterprise Contract Lifecycle Management needs," said Patrick Stakenas, President and CEO of Determine. "Over the coming months, we look forward to continuing to focus on several key executional tasks including advancing the Determine Cloud Platform's capabilities -- to provide our customers with 'Platformance', continuing to optimize organizational efficiencies, and building upon our robust lead pipeline to deliver incremental and accelerated sales in the coming quarters."

Q3 FY2017 Business Highlights:

  • Annualized Bookings: The sales team delivered approximately $983,000 in Annualized Bookings for the quarter, with more than 90% of new customers selecting the new Determine Cloud Platform for their Source-to-Pay or Contract Lifecycle Management needs.
  • Determine Cloud Platform Empowers Companies in Source-to-Pay and Enterprise Contract Lifecycle Management: During Q3 FY2017, Determine introduced a range of additional benefits that empower customers to deliver results now, and as they grow. These include the following improvements to the Determine Cloud Platform : improved supplier certification and compliance through triggered automation based on answers provided during registration and supplier monitoring, side-by-side comparison of contract requests and attachments for enhanced version control and user authorization, time tracking for services procurement that requires calendar management, PO matching, and automatic receipt/invoice generation. In addition, the Determine Cloud Platform mobile application is now available on Google Play and the Apple Store.
  • Business Analyst Recognition across the Determine Cloud Platform: In Q3 FY2017, Determine achieved a number of important recognitions from leading industry analyst organizations:
  • New Leadership: In October 2016, Determine appointed Steve Potts as Chief Revenue Officer. Steve brings over thirty years of sales management, sales performance management, and sales training experience in the enterprise software and SaaS sectors. He most recently served as Chief Sales and Marketing Officer at AXIOM Sales Force Development, a leading cloud-based sales training and productivity improvement supplier.
  • New Customer Expansions: During Q3 FY2017, Determine engaged numerous new customer accounts in the US and Europe across its Determine Cloud Platform Source-to-Pay and Enterprise Contract Lifecycle Management solutions. Determine added new customers to its portfolio including companies in key verticals such as energy, financial, healthcare products, consumer goods, manufacturing, and retail.
  • Thought Leadership: In Q3 FY2017, Determine continued to provide meaningful educational resources to inform our customers and prospects on the ever-changing Source-to-Pay and Enterprise Contract Lifecycle Management landscape:

Conference Call and Webcast: Thursday, February 9, 2017 at 5:00 PM (Eastern Time) Participant Conference Call Numbers: Toll-Free: 1-877- 407-0789 Toll/International: 1-201- 689-8562 Participant Webcast Link: http://public.viavid.com/index.php?id=122692 Replay Dial-in Information: Toll-Free: 1-844- 512-2921 Toll/International: 1-412- 317-6671 From: 02/09/17 @ 8:00 pm Eastern Time To: 02/16/17 @ 11:59 pm Eastern Time Replay Pin Number: 13653707 Related: http://investor.determine.com

Supporting Resources Determine blog Determine on LinkedIn Determine on Twitter Determine Resources

Non-GAAP Financial Measures

To supplement our financial results presented in accordance with Generally Accepted Accounting Principles (GAAP), this press release and the accompanying tables contain certain non-GAAP financial measures, including non-GAAP revenue, non-GAAP gross profit, non-GAAP net income and non-GAAP earnings per share, which we believe are helpful in understanding our past financial performance and future results. For reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures, please see the section of the accompanying tables titled, "GAAP to Non-GAAP Reconciliations". Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The difference between GAAP and non-GAAP revenue is due to the impact of revaluing the deferred revenue balances acquired from primarily b-pack, Inc. as required by GAAP purchase accounting.

The difference between GAAP and non-GAAP gross profit is the difference in GAAP versus non-GAAP revenues as well as the elimination of the amortization of acquisition related intangibles, stock based compensation and severance expense from the costs of revenue. Non-GAAP net loss excludes the non-GAAP gross profit items as well as acquisition related costs.

Our management regularly uses our supplemental non-GAAP financial measures internally to understand and manage our business and forecast future periods; as such, we believe it is useful for investors to understand the effects of these items on our total operations. Further, please note that our non-GAAP revenue is intended to reflect the full amount of revenues that would have been otherwise recorded by the acquired entities of Iasta.com, Inc. and b-pack, Inc. while our non-GAAP gross profit also excludes the amortization of intangibles that occurred due to the acquisition of the entities of Iasta.com, Inc. and b-pack, Inc.

Annualized Bookings are an operating measure not derived from the company's revenues or any other amounts presented in accordance with GAAP in the company's statement of income, balance sheet, statement of cash flows or other equivalent statements.

"Annualized Bookings" means the annualized recurring contracted revenue from a new customer or a cross-sell or upsell to an existing customer.

Forward-looking Statements

Certain statements in this release and elsewhere by Determine are forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements regarding business outlook, assessment of market conditions, anticipated financial and operating results, strategies, product and channel development, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward-looking statements include, but are not limited to fluctuations in demand for Determine's products and services, risks of losing key personnel or customers, protection of the company's intellectual property and government policies and regulations, including, but not limited to those affecting the company's industry. Determine undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Additional risk factors concerning the company can be found in the company's most recent Form 10-K as filed by the company with the Securities and Exchange Commission.

About Determine, Inc.

Determine, Inc. ( NASDAQ : DTRM ) is a leading global provider of SaaS Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) solutions. Our visionary technologies allow our customers to effectively manage the full scope of Source-to-Pay and Enterprise Contract Lifecycle Management using our Determine Cloud Platform. Our Source to Pay SaaS suite includes strategic sourcing, supplier management, contract management and procure-to-pay applications.

The Determine Cloud Platform gives procurement, finance and legal professionals the ability to deliver profound insights through analysis of their supplier relationships and contractual requirements. Our customers leverage the Determine Cloud Platform to discover previously unseen supplier and spend data; make more informed and smarter business decisions; drive new revenue; control costs; improve workflow efficiencies; and mitigate risk.

Our customers benefit from the Determine Cloud Platform's robust suite of integrated applications. Whether they start with a full-suite implementation or choose to implement just one application and build over time, each application allows for the automatic sharing of data in place on the Determine Cloud Platform.

For more information, please visit: www.determine.com .

   
   
   
Determine, Inc.  
Condensed Consolidated Statements of Operations  
(In thousands, except per share amounts)  
(Unaudited)  
               
      Three Months Ended     Nine Months Ended  
      December 31     December 31  
      2016     2015     2016     2015  
                                   
Revenues:                              
  Recurring revenues $ 5,054       5,354     $ 15,267     $ 15,862  
  Non-recurring revenues   1,798       1,746       4,661       4,218  
  Total revenues   6,852       7,100       19,928       20,080  
                                   
Cost of revenues:                              
  Cost of recurring revenues   1,777       1,816       5,085       5,003  
  Cost of non-recurring revenues   1,734       1,602       4,978       4,583  
  Total cost of revenues   3,511       3,418       10,063       9,586  
                                   
Gross profit:                              
  Recurring gross profit   3,277       3,538       10,182       10,859  
  Non-recurring profit (loss)   64       144       (317 )     (365 )
  Total gross profit   3,341       3,682       9,865       10,494  
                                   
Operating expenses:                              
  Research and development   1,049       1,230       3,052       2,851  
  Sales and marketing   2,273       3,310       7,843       10,313  
  General and administrative   1,761       2,072       5,432       6,211  
  Impairment of software devlopment costs   -       -       947          
    Total operating expenses   5,083       6,612       16,327       19,375  
                                   
Loss from operations   (1,742 )     (2,930 )     (6,462 )     (8,881 )
                                   
Interest and other (expense), net   (462 )     (149 )     (1,388 )     (549 )
Net loss before income tax   (2,204 )     (3,079 )     (7,850 )     (9,430 )
                                   
Benefit from income taxes   35       233       143       213  
Net loss   (2,169 )     (2,846 )     (7,707 )     (9,217 )
                                   
Net income (loss) attributed to non-controlling interest   (24 )     1       (36 )     5  
Net loss attributable to Determine, Inc.   (2,193 )     (2,845 )     (7,743 )     (9,212 )
                                   
Redeemable preferred stock accretion   -       -       -       1,000  
Net loss attributable to common stockholders $ (2,193 )   $ (2,845 )   $ (7,743 )   $ (10,212 )
                                   
Basic and diluted net loss per share $ (0.18 )   $ (0.25 )   $ (0.67 )   $ (0.90 )
                                   
                           
                           
Determine, Inc.  
GAAP to Non-GAAP Reconciliations  
(In thousands)  
(Unaudited)  
                                   
Reconciliation of total revenue:                              
  U.S. GAAP as reported $ 6,852     $ 7,100     $ 19,928     $ 20,080  
  Adjustments:                              
  Deferred revenue adjustment   -       87       8       228  
Non-GAAP revenue $ 6,852     $ 7,187     $ 19,936     $ 20,308  
                                   
Reconciliation of gross profit:                              
  U.S. GAAP as reported $ 3,341     $ 3,682     $ 9,865     $ 10,494  
  Adjustments:                              
  Deferred revenue adjustment   -       87       8       228  
  Amortizaton of acquision   250       250       758       630  
  Stock based compensation   111       92       240       218  
  Severance   24       24       25       107  
Non-GAAP gross profit $ 3,726     $ 4,135     $ 10,896     $ 11,677  
                                   
Reconciliation to non-GAAP net loss:                              
Net loss $ (2,193 )   $ (2,845 )   $ (7,743 )   $ (9,212 )
Stock-based compensation expense   630       658       1,867       1,871  
Deferred revenue adjustment   -       87       8       228  
Acquisition related costs   -       138       -       912  
Amortization on intangibles   526       542       1,594       1,373  
Benefit for income taxes   -       (213 )     (13 )     (213 )
Severance costs   27       130       34       456  
Non-GAAP net loss $ (1,010 )   $ (1,503 )   $ (4,253 )   $ (4,585 )
                                   
Non-GAAP basic and diluted net loss per share $ (0.08 )   $ (0.13 )   $ (0.37 )   $ (0.45 )
                                   
Weighted average shares outstanding for basic                              
and diluted net loss per share   11,944       11,244       11,466       10,212  
                                   
                         
                         
Determine, Inc.  
Condensed Consolidated Statements of Comprehensive Loss  
(In thousands)  
(Unaudited)  
   
    Three Months Ended     Nine Months Ended  
    December 31     December 31  
    2016     2015     2016     2015  
                                 
Net loss   $ (2,169 )   $ (2,846 )   $ (7,707 )   $ (9,217 )
Other comprehensive income (loss) net:                                
  Foreign currency translation adjustments     44       (11 )     31       (68 )
  Non-controlling interest     (24 )     1       (36 )     5  
Other comprehensive income (loss)     20       (10 )     (5 )     (63 )
Comprehensive loss   $ (2,149 )   $ (2,856 )   $ (7,712 )   $ (9,280 )
                                 
                                 
         
Determine, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
         
         
         
    December 31,   March 31,
    2016   2016
    (Unaudited)   (Audited)
ASSETS            
Current assets            
  Cash and cash equivalents   $ 9,387   $ 9,418
  Accounts receivable, net     6,759     7,031
  Restricted cash     34     34
  Prepaid expenses and other current assets     1,408     1,551
    Total current assets     17,588     18,034
             
Property and equipment, net     94     136
Capitalized software, net     2,131     1,699
Goodwill     14,346     14,490
Other intangibles, net     6,346     8,011
Other assets     1,492     1,843
    Total assets   $ 41,997   $ 44,213
             
             
LIABILITIES AND EQUITY            
Current liabilities            
  Credit facility   $ 10,861   $ 9,000
  Accounts payable     2,435     1,973
  Accrued payroll and related liabilities     1,802     1,655
  Other accrued liabilities     2,020     2,396
  Deferred revenue     10,028     10,299
  Income tax payable     78     14
  COFACE loan     222     407
  Accrued restructuring     -     403
    Total current liabilities     27,446     26,147
  Long-term deferred revenue     5     67
  Convertible note, net of debt discount     7,374     5,420
  Other long-term liabilities     1,055     1,382
  Deferred tax liability non current     81     290
    Total liabilities     35,961     33,306
             
Total Determine, Inc. stockholders' equity controlling interest     5,887     10,794
Non-controlling interest     149     113
Total equity     6,036     10,907
    Total liabilities and equity   $ 41,997   $ 44,213
             
             
             
Determine, Inc.  
Condensed Consolidated Statements of Cash Flows  
(In thousands)  
(Unudited)  
             
             
    Nine Months Ended  
    December 31,     December 31,  
    2016     2015  
                 
Operating activities                
Net loss   $ (7,707 )   $ (9,217 )
Adjustments to reconcile net loss to net cash used in                
operating activities:                
  Depreciation and amortization     2,478       1,868  
  Loss on disposition of property and equipment     -       14  
  Stock-based compensation expense     1,867       1,870  
  Deferred tax liability     (209 )     93  
Changes in assets and liabilities:                
  Accounts receivable, net     272       149  
  Prepaid expenses and other current assets     143       300  
  Other assets     435       (380 )
  Accounts payable     462       113  
  Accrued payroll and related liabilities     147       278  
  Accrued restructuring costs     (403 )     -  
  Other accrued liabilities and other long-term liabilities     (356 )     (13 )
  Deferred revenue     (333 )     (281 )
Net cash used in operating activities     (3,204 )     (5,206 )
                 
Investing activities                
  Purchase of property and equipment     (39 )     (6 )
  Capitalized software     (1,267 )     (1,077 )
  Purchase of business, net of cash     -       (826 )
  Minority shareholder payment     -       (133 )
Net cash used in investing activities     (1,306 )     (2,042 )
                 
Financing activities                
  Proceeds from sale of common stock, preferred stock and warrants, net of issuance costs     -       310  
  Employee taxes paid in exchange for restricted stock awards forefeited     78       263  
  Issuance of common stock under employee stock plan     80       87  
  Credit facility borrowing     3,000       885  
  Credit facility payment     (1,139 )     (347 )
  Repayment of loan     (185 )     (25 )
  Conversion of preferred stock to common stock     -       (17 )
  Issuance of debt, net of costs     2,429       2,743  
Net cash provided by financing activities     4,263       3,899  
                 
  Effect of exchange rate changes on cash     216       11  
                 
Net decrease in cash and cash equivalents     (31 )     (3,338 )
Cash and cash equivalents at beginning of the period     9,418       13,178  
Cash and cash equivalents at end of the period   $ 9,387     $ 9,840  
                 
                         
                         
Determine, Inc.  
Billings Reconciliation  
(In thousands)  
(Unaudited)  
                         
                         
    Three Months Ended     Nine Months Ended  
    December 31,     December 31,     December 31,     December 31,  
    2016     2015     2016     2015  
                                 
Total revenues   $ 6,852     $ 7,100     $ 19,928     $ 20,080  
Deferred revenue:                                
End of period     10,033       9,019       10,033       9,019  
Beginning of period     9,340       8,319       10,366       8,432  
Change in deferred revenue     693       700       (333 )     587  
Total billings (total revenues plus the change in deferred revenue)   $ 7,545     $ 7,800     $ 19,595     $ 20,667  
                                 
                                 
                                 
Determine, Inc.  
Non-GAAP EBITDA Reconciliation  
(In thousands)  
(unaudited)  
                         
    Three Months Ended     Nine Months Ended  
    December 31     December 31  
    2016     2015     2016     2015  
Reconciliation to non-GAAP EBITDA net loss:                                
Non-GAAP net loss   $ (1,010 )   $ (1,503 )   $ (4,253 )   $ (4,585 )
Interest     461       131       1,299       372  
Depreciation     348       161       916       498  
Income Taxes and Minority Shareholder     (11 )     (233 )     (107 )     (217 )
Non-GAAP EBITDA net loss   $ (212 )   $ (1,444 )   $ (2,145 )   $ (3,932 )
                                 

 

Contact Media Relations Rose Lee Determine, Inc. +1.877.806.1932 +1.650.532.1590 pr@determine.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
Law Firm Gains Strength with Strategic New Hires

Updated Category News Views 1

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 3

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 3

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 1

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 1

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
Facility Solutions Group Climbs to Top 18 Electrical Spot

Updated Category News Views 2

FSG Shines Brightly in Electrical Contractor Rankings Climbing the ladder is no easy feat, but Facility Solutions Group (FSG) has managed to climb, all the way to the #18 spot on Electrical Construction & Maintenance (EC&M) magazine's revered list of the Top Electrical Contractors in the U.S. It’s up from their previous rank of 22. When you think about the competitive...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading

Top 5 Most Recently Viewed Articles

Freddie Mac's Strategic Sale of $438 Million NPLs

Updated Category News Views 107

Freddie Mac Moves Forward with Significant NPL Sale Freddie Mac is taking bold steps to reshape its mortgage investments strategy by selling a substantial portfolio of non-performing loans (NPLs). With a total balance of around $438 million, this sale, which involves 2,201 deeply delinquent residential first lien loans, emphasizes Freddie Mac's continued commitment to...

Continue Reading
Replenish Nutrients Unveils Beiseker Facility Progress and Vision

Updated Category News Views 257

Replenish Nutrients Unveils Beiseker Facility Progress Replenish Nutrients Holding Corp. (CSE: ERTH, OTC: VVIVF) has exciting news regarding significant advancements at its Beiseker manufacturing facility. The company is nearing completion of substantial upgrades to the facility, achieving approximately 90% of its renovation goals. The finishing touches include...

Continue Reading
Smartphones Market Growth: $520 Billion Potential by 2030

Updated Category News Views 611

Transformation in the Global Smartphones Market The global smartphones market is on a remarkable growth trajectory, set to expand its valuation significantly in the coming years. Current projections indicate that the market could grow from approximately US$ 273.9 billion to a staggering US$ 520.7 billion by the year 2030, driven by a compound annual growth rate (CAGR) of...

Continue Reading
Growth Trends in the Philippines Generator Market Beyond 2025

Updated Category News Views 222

The Expanding Philippines Generator Market: An Overview The generator market in the Philippines is experiencing a significant transformation as it is projected to expand from a valuation of US$151.16 million in 2024 to an impressive US$360.82 million by 2035. This growth, characterized by a compound annual growth rate (CAGR) of 8.29% during the 2025–2035 period, is...

Continue Reading
MoonLake Immunotherapeutics Faces Securities Class Action Lawsuit

Updated Category News Views 194

MoonLake Immunotherapeutics Faces Class Action Lawsuit MoonLake Immunotherapeutics, a dynamic player in the biopharmaceutical sector, is drawing attention due to a recent class action lawsuit associated with securities fraud. This lawsuit has been initiated in light of serious allegations against the company regarding misleading information about its leading drug...

Continue Reading